Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Preclinical Studies Database
  • Healthcare Investors
  • Healthcare Companies
  • Pharma News

Tag Archives: Cellectis

Cellectis – gene-editing

Posted on by

Cellectis is a biotech company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART).

Cellectis – gene-editing

Cellectis

Continue reading →

Posted in Biotech Companies, Biotech Companies France | Tagged Acute lymphoblastic leukemia, Acute myeloid leukemia, adoptive immunotherapies, adoptive immunotherapy, Alain Godard, ALCLS, ALL, allogeneic T cells engineered, AML, André Choulika, Annick Schwebig, autologous adoptive immunotherapies, autologous adoptive immunotherapy, B cells malignancies, CAR, CAR-engineered cell, Cellectis, Cellectis - gene-editing, Chimeric Antigen Receptor, Chronic lymphocytic leukemia, CLL, David Sourdive, electroporation PulseAgile technology, engineered nuclease, engineered nucleases, gene edited engineered CAR-T cell, gene edited engineered CAR-T cells, gene edited engineered T cell, gene engineering, gene-editing, genome engineering, glioblastoma, immunotherapies, immunotherapy, Laurent Arthaud, leukemia, Mathieu Simon, meganuclease, meganucleases, Multiple myeloma, non-small-cell lung cancer, pancreatic cancer, Philippe Duchateau, Pierre Bastid, PulseAgile, T cells, T-cell, TALEN, TALEN products, Thierry Moulin, UCART

Do you need to raise your next Funding round? In-Licensing / Out-Licensing of your assets? Distribution / Commercialization of your products? Want to create a spin-off with your IP?

Contact us!

Do you need a specific database in Healthcare (researchers, Biotech/Pharma companies, CRO/CDMO, etc.)?

Contact us!

Contact              Offers - Services - Licensing - Funding               Healthcare Venture Building               Biotech Jobs               Biotech & Pharma News
Proudly powered by WordPress